RDVIX
Price
$5.59
Change
-$0.04 (-0.71%)
Updated
Mar 11 closing price
Net Assets
63.57M
VIMSX
Price
$69.71
Change
-$0.60 (-0.85%)
Updated
Mar 11 closing price
Net Assets
181.84B
Ad is loading...

RDVIX vs VIMSX

Header iconRDVIX vs VIMSX Comparison
Open Charts RDVIX vs VIMSXBanner chart's image
Royce Dividend Value Invmt
Price$5.59
Change-$0.04 (-0.71%)
VolumeN/A
Net Assets63.57M
Vanguard Mid Cap Index Investor
Price$69.71
Change-$0.60 (-0.85%)
VolumeN/A
Net Assets181.84B
RDVIX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RDVIX vs. VIMSX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDVIX is a Buy and VIMSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 182B vs. RDVIX (63.6M). RDVIX pays higher dividends than VIMSX: RDVIX (3.24) vs VIMSX (1.33). RDVIX was incepted earlier than VIMSX: RDVIX (18 years) vs VIMSX (27 years). RDVIX (1.27) is less costly to investors than VIMSX (0.17). RDVIX has a lower initial minimum investment than VIMSX: RDVIX (2000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 5.57 vs. RDVIX (-10.69). VIMSX return over 5 years is better than : 98.73 vs. RDVIX (43.86).
RDVIXVIMSXRDVIX / VIMSX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.270.17747%
Fund Existence18 years27 years-
Gain YTD-5.892-2.442241%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets63.6M182B0%
Annual Yield % from dividends3.241.33243%
Returns for 1 year-10.695.57-192%
Returns for 3 years1.4616.739%
Returns for 5 years43.8698.7344%
Returns for 10 years-18.66107.54-17%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTCT4.230.36
+9.30%
BTC Digital Ltd
LXU7.050.13
+1.88%
LSB Industries
XENE34.780.51
+1.50%
Xenon Pharmaceuticals
LXRX0.36N/A
+1.13%
Lexicon Pharmaceuticals
RVTY112.92-5.31
-4.49%
Revvity